Nordic Capital is to acquires a majority share in IntegriChain, a provider of pharmaceutical technology, data, consulting, and outsourcing solutions designed to improve how life sciences products reach customers.
IntegriChain delivers ICyte, a fully integrated platform for commercialisation and market access, helping manufacturers bring their science to market while ensuring patients have affordable, timely, and sustainable access to therapy.
Get the week’s top news delivered directly to your inbox – Sign up for our newsletter
Nordic Capital is acquiring the majority stake from Accel-KKR, a global software private equity firm, which first invested in IntegriChain in 2016.
Terms of the transaction, which is expected to complete before the end of the year subject to customary closing conditions, have not been disclosed.
Source: PrivateEquityWire
Can’t stop reading? Read more
Advance Capital Partners to acquire 60% stake in Mass in major Adriatic retail deal
Advance Capital Partners to acquire 60% stake in Mass in major Adriatic retail deal Advance...
Neuberger Berman closes $2.8bn co-investment fund, exceeding target as LP demand accelerates
Neuberger Berman closes $2.8bn co-investment fund, exceeding target as LP demand accelerates...
Ardian to acquire majority stake in high-voltage specialist MasterGrid from Andera Partners
Ardian to acquire majority stake in high-voltage specialist MasterGrid from Andera Partners Ardian...